These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 22155105)
41. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model. Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277 [TBL] [Abstract][Full Text] [Related]
42. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy. Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420 [TBL] [Abstract][Full Text] [Related]
43. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways. Chintharlapalli S; Papineni S; Safe S Mol Pharmacol; 2007 Feb; 71(2):558-69. PubMed ID: 17093136 [TBL] [Abstract][Full Text] [Related]
44. Dose-Dependent Responses of I3C and DIM on T-Cell Activation in the Human T Lymphocyte Jurkat Cell Line. Liu M; Yasmeen R; Fukagawa NK; Yu L; Kim YS; Wang TTY Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671563 [TBL] [Abstract][Full Text] [Related]
45. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223 [TBL] [Abstract][Full Text] [Related]
46. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633 [TBL] [Abstract][Full Text] [Related]
47. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling. Deep G; Gangar SC; Oberlies NH; Kroll DJ; Agarwal R Mol Carcinog; 2010 Oct; 49(10):902-12. PubMed ID: 20721970 [TBL] [Abstract][Full Text] [Related]
48. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. Raffoul JJ; Wang Y; Kucuk O; Forman JD; Sarkar FH; Hillman GG BMC Cancer; 2006 Apr; 6():107. PubMed ID: 16640785 [TBL] [Abstract][Full Text] [Related]
49. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
50. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA]. Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562 [TBL] [Abstract][Full Text] [Related]
51. Bakuchiol exhibits anti-metastasis activity through NF-κB cross-talk signaling with AR and ERβ in androgen-independent prostate cancer cells PC-3. Miao L; Yun X; Tao R; Wang Y; Fan G; Zhu Y; Cai T; Zhu Z; Yan C; Gao X J Pharmacol Sci; 2018 Sep; 138(1):1-8. PubMed ID: 30236540 [TBL] [Abstract][Full Text] [Related]
52. The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells. Palomera-Sanchez Z; Watson GW; Wong CP; Beaver LM; Williams DE; Dashwood RH; Ho E J Nutr Biochem; 2017 Sep; 47():113-119. PubMed ID: 28582660 [TBL] [Abstract][Full Text] [Related]
53. Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance. Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z FASEB J; 2020 Sep; 34(9):11511-11528. PubMed ID: 32713076 [TBL] [Abstract][Full Text] [Related]
54. Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. Chen DZ; Qi M; Auborn KJ; Carter TH J Nutr; 2001 Dec; 131(12):3294-302. PubMed ID: 11739883 [TBL] [Abstract][Full Text] [Related]
55. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Wang LG; Liu XM; Chiao JW Carcinogenesis; 2006 Oct; 27(10):2124-32. PubMed ID: 16704988 [TBL] [Abstract][Full Text] [Related]
56. Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy. Siddique HR; Mishra SK; Karnes RJ; Saleem M Clin Cancer Res; 2011 Aug; 17(16):5379-91. PubMed ID: 21712449 [TBL] [Abstract][Full Text] [Related]
57. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
59. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366 [TBL] [Abstract][Full Text] [Related]
60. Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells. Zhang Y; Kim KH; Zhang W; Guo Y; Kim SH; Lü J Int J Cancer; 2012 Jan; 130(1):200-12. PubMed ID: 21328348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]